Showing results (771-780 of 2,482) with videos related to

Sort By:
Pageof 249
Clinical and Translational Science|August 18, 2020
Past, Current, and Future Cancer Clinical Research Collaborations: The Case of the European Organisation for Research and Treatment of CancerStefanie Broes, Robbe Saesen, Denis Lacombe, et al.
Clinical and Translational Science|April 1, 2023
A multi-purpose Japanese phase I study in the global development of vupanorsen: Randomized, placebo-controlled, single-ascending dose study in adultsKei Fukuhara, Kenichi Furihata, Nobushige Matsuoka, et al.
Clinical and Translational Science|May 11, 2023
Exposure-response analysis for nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma (CheckMate 040)Bruno Sangro, Thomas Yau, Anthony B El-Khoueiry, et al.
Clinical and Translational Science|July 24, 2020
Standardized Data Structures in Rare Diseases: CDISC User Guides for Duchenne Muscular Dystrophy and Huntington's DiseaseAriana P Mullin, Diane Corey, Emily C Turner, et al.
Clinical and Translational Science|June 30, 2020
Identification of Critical Windows of Metabolic Programming of Metabolism and Lung Function in Male Offspring of Obese DamsKatharina Dinger, Silke V Koningsbruggen-Rietschel, Jörg Dötsch, et al.
Clinical and Translational Science|July 22, 2020
Exocrine Pancreatic Dysfunction Increases the Risk of New-Onset Diabetes Mellitus: Results of a Nationwide Cohort StudyJaelim Cho, Robert Scragg, Stephen J Pandol, et al.
Clinical and Translational Science|June 26, 2020
Early M-Protein Dynamics Predicts Progression-Free Survival in Patients With Relapsed/Refractory Multiple MyelomaXiaoyu Yan, Xu Steven Xu, Katja C Weisel, et al.
Clinical and Translational Science|June 26, 2020
A Pooled Analysis of Three Randomized Phase I/IIa Clinical Trials Confirms Absence of a Clinically Relevant Effect on the QTc Interval by UmibecestatStefan Viktor Vormfelde, Nicole Pezous, Gilbert Lefèvre, et al.
Clinical and Translational Science|June 27, 2020
Safety, Tolerability, and Pharmacokinetics of Remdesivir, An Antiviral for Treatment of COVID-19, in Healthy SubjectsRita Humeniuk, Anita Mathias, Huyen Cao, et al.
Pageof 249